Atenolol pharmacokinetics in patients on continuous ambulatory peritoneal dialysis. 1984

A K Salahudeen, and R Wilkinson, and J McAinsh, and D N Bateman

The elimination of atenolol (20 mg i.v.) has been studied in seven patients with renal failure on continuous ambulatory peritoneal dialysis (CAPD). Although atenolol was eliminated in the peritoneal fluid, the amount recovered in 24 h was relatively low (1.2 +/- 0.15 mg). The calculated urinary (n = 4) and peritoneal (n = 7) clearance was 0.289 +/- 0.058 l/h and 0.152 +/- 0.018 l/h respectively. This was considerably less than calculated total body clearance (1.21 +/- 0.086 l/h). The kinetics of atenolol in CAPD are worthy of further study.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D011674 Pulse The rhythmical expansion and contraction of an ARTERY produced by waves of pressure caused by the ejection of BLOOD from the left ventricle of the HEART as it contracts. Pulses
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001262 Atenolol A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect. ICI-66082,Tenormin,Tenormine,ICI 66082,ICI66082

Related Publications

A K Salahudeen, and R Wilkinson, and J McAinsh, and D N Bateman
December 1987, Clinical nephrology,
A K Salahudeen, and R Wilkinson, and J McAinsh, and D N Bateman
January 1986, Nephron,
A K Salahudeen, and R Wilkinson, and J McAinsh, and D N Bateman
January 1986, European journal of clinical pharmacology,
A K Salahudeen, and R Wilkinson, and J McAinsh, and D N Bateman
January 1981, Clinical and experimental dialysis and apheresis,
A K Salahudeen, and R Wilkinson, and J McAinsh, and D N Bateman
January 1987, European journal of clinical pharmacology,
A K Salahudeen, and R Wilkinson, and J McAinsh, and D N Bateman
March 1985, Clinical nephrology,
A K Salahudeen, and R Wilkinson, and J McAinsh, and D N Bateman
October 1996, Clinical pharmacokinetics,
A K Salahudeen, and R Wilkinson, and J McAinsh, and D N Bateman
September 1987, The American journal of cardiology,
A K Salahudeen, and R Wilkinson, and J McAinsh, and D N Bateman
February 1988, Antimicrobial agents and chemotherapy,
A K Salahudeen, and R Wilkinson, and J McAinsh, and D N Bateman
July 1992, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!